ResQ133A-NMIBC: Intravesical Recombinant Mycobacterium (rMBCG) in Participants With NMIBC Eligible to Receive Intravesical Tice BCG
Abroad (travel likely)RecruitingPHASE1, PHASE2
Conditions
NMIBC
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Arizona Clinical Trials, Chandler, Arizona, United States
Contact: Principal Investigator (Patel Pratik, MD)Golden State Urology, Sacramento, California, United States
Contact: Principal Investigator (Prithipal Sethi, MD)Emory University, Atlanta, Georgia, United States
Contact: Principal Investigator (Shreyas Joshi, MD)Michigan Institute of Urology & Solaris Health, Troy, Michigan, United States
Contact: Principal Investigator (Jason Hafron, MD)SUNY Upstate Medical University, Syracuse, New York, United States
Contact: Principal Investigator (Joseph Jacob, MD)MidLantic Urology, Cynwyd, Pennsylvania, United States
Contact: Principal Investigator (Lawrence Belkoff, DO)Conrad Pearson Clinic, Germantown, Tennessee, United States
Contact: Principal Investigator (Ravi Chauhan, MD)Urology Associates, P.C., Nashville, Tennessee, United States
Contact: Principal Investigator (Gautam Jayram, MD)Potamac Urology Center, Alexandria, Virginia, United States
Contact: Principal Investigator (Aseem Malhotra, MD)